Strategy

Our purpose is to reimagine medicine to improve and extend people's lives.

Our vision is to become the most valued and trusted medicines company in the world.

Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Focus Areas

To support this strategy, we have clear focus areas and priorities to create value for our company, our shareholders and society.

Therapeutic areas

Cardiovascular

Cardiovascular disease (CVD), which includes chronic conditions affecting the heart and blood vessels such as heart failure, heart attacks and strokes, is the world's leading cause of death and one of society's biggest health concerns.

Immunology

Immunology covers a broad spectrum of conditions, including chronic skin diseases such as psoriasis and hidradenitis suppurativa. Autoimmune conditions alone, which form a small part of immunological diseases, affect an estimated 4.5% of the world’s population and their prevalence is increasing.

Neuroscience

Around 2 million people worldwide suffer from multiple sclerosis (MS), an autoimmune disease that is the most common cause of neurological disability unrelated to trauma in people under 40 years of age.

Solid tumors

Cancer is the second leading cause of death worldwide. The World Health Organization (WHO) estimates there will be 50% more new cancer cases in 2040 than there are today. At Novartis, we’re committed to unraveling the inner workings of cancer. We’re developing new therapies for a range of common and rare cancers, investing in diverse technology platforms and experimenting with combination approaches.

Hematology

Hematology encompasses both malignant cancers and non-malignant disorders of the blood and blood components, such as blood cells and bone marrow cells. There are many different causes of these cancers and disorders, and prognosis can vary significantly among the different illnesses.

Technology platforms

Chemistry

Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.

Biotherapeutics

Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.

xRNA

RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.

Radioligand

Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.

Gene and cell therapy

Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.

Our Strategic Priorities

Strategy

Our purpose is to reimagine medicine to improve and extend people's lives.

Our vision is to become the most valued and trusted medicines company in the world.

Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Focus Areas

Therapeutic areas

Cardiovascular

Cardiovascular disease (CVD), which includes chronic conditions affecting the heart and blood vessels such as heart failure, heart attacks and strokes, is the world's leading cause of death and one of society's biggest health concerns.

Immunology

Immunology covers a broad spectrum of conditions, including chronic skin diseases such as psoriasis and hidradenitis suppurativa. Autoimmune conditions alone, which form a small part of immunological diseases, affect an estimated 4.5% of the world’s population and their prevalence is increasing.

Neuroscience

Around 2 million people worldwide suffer from multiple sclerosis (MS), an autoimmune disease that is the most common cause of neurological disability unrelated to trauma in people under 40 years of age.

Solid tumors

Hematology

Hematology encompasses both malignant cancers and non-malignant disorders of the blood and blood components, such as blood cells and bone marrow cells. There are many different causes of these cancers and disorders, and prognosis can vary significantly among the different illnesses.

Technology platforms

Chemistry

Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.

Biotherapeutics

Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.

xRNA

RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.

Radioligand

Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.

Gene and cell therapy

Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.

Our Strategic Priorities

Deliver high-value medicines

Embed operational excellence

Strengthen our foundations:

AddToAny buttons

Printable Links Block (Content)